靶点针对疾病信息20(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T84160
TARGNAME
5-HT 3 receptor (5HT3R)
INDICATI
Approved Irritable bowel syndrome [ICD-11: DD91]
INDICATI
Approved Nausea/vomiting [ICD-11: MD90]
INDICATI
Approved Substance abuse [ICD-11: 6C40]
INDICATI
Phase 3 Anxiety disorder [ICD-11: 6B00-6B0Z]
INDICATI
Phase 3 Mood disorder [ICD-11: 6A60-6E23]
INDICATI
Phase 2 Gastro-oesophageal reflux disease [ICD-11: DA22]
INDICATI
Phase 2 Oesophageal/gastroduodenal disorder [ICD-11: DD90]
INDICATI
Phase 2 Opioid use disorder [ICD-11: 6C43]
INDICATI
Phase 1 Depression [ICD-11: 6A70-6A7Z]
INDICATI
Phase 1 Sex development malformative disorder [ICD-11: LD2A]
INDICATI
Discontinued in Phase 2 Oesophagus motility disorder [ICD-11: DA21]
INDICATI
Terminated Unspecific substance use disorder [ICD-11: 6C4Z]
INDICATI
Investigative Dementia [ICD-11: 6D80-6D8Z]
INDICATI
Investigative Obesity [ICD-11: 5B80-5B81]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3